Novel Long-Acting Buprenorphine Medications for Opioid Dependence: Current Update

Soyka, Michael (2020): Novel Long-Acting Buprenorphine Medications for Opioid Dependence: Current Update. In: Pharmacopsychiatry, Bd. 54, Nr. 01: S. 18-22

Abstract

Opioid maintenance treatment with oral methadone or sublingual buprenorphine is the first-line treatment in opioid dependence. Three novel long-acting buprenorphine formulations have been approved or will be available soon: for subcutaneous weekly and monthly application, the depot formulations CAM 2038 (Buvidal ((R)) ), the monthly depot formulation RBP-6000 (Sublocade (TM)), and a 6-month buprenorphine implant (Probuphine (TM)). Clinical data available so far on the efficacy of these 3 medications are given, and possible clinical implications are discussed.

• Dokumententyp: Zeitschriftenartikel
• Fakultät: Medizin
• Themengebiete: 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit
• ISSN: 0176-3679
• Sprache: Englisch